Roth MKM Initiates Coverage On CG Oncology With Buy Rating, Announces Price Target of $65
Roth MKM Initiates Coverage On CG Oncology With Buy Rating, Announces Price Target of $65
Roth MKm對CG Oncology發起買入評級,宣佈目標價格爲65美元。
Roth MKM analyst Benjamin Paluch initiates coverage on CG Oncology (NASDAQ:CGON) with a Buy rating and announces Price Target of $65.
Roth MKm 分析師Benjamin Paluch發起對CG Oncology(納斯達克:CGON)的覆蓋,並給予買入評級,目標價爲65美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。